Study 437 Assessment of Adefovir Dipivoxil 30 mg

• Efficacy demonstrated with ADV 10 and 30 mg

• Renal laboratory abnormalities with ADV 30 mg

• Safety profile of ADV 10 mg similar to placebo and favorable for long-term dosing

Previous slide

Next slide

Back to first slide

View graphic version